Cytokinetics pharmaceuticals stock
WebApr 11, 2024 · EDMONTON, Alberta, April 11, 2024 -- ( BUSINESS WIRE )--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the United States Patent and Trademark Office... WebApr 5, 2024 · CYTOKINETICS, INCORPORATED : News, information and stories for CYTOKINETICS, INCORPORATED Nasdaq: CYTK Nasdaq ... VERTEX PHARMACEUTICALS INCORPORATED : Q1 2024 Earnings Release (Projected) 05/04/23: ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
Cytokinetics pharmaceuticals stock
Did you know?
WebMar 7, 2024 · Cytokinetics (Nasdaq:CYTK) earnings and revenue forecasts, price targets, future return on equity. ... President & Director exercised options and sold US$333k worth of stock Aug 04. Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M ... High growth companies in the Pharmaceuticals & Biotech industry. WebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function.
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision Leadership … WebNov 8, 2024 · Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional $18.0 million aggregate principal amount of the notes in connection with the offering, solely to cover...
WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated … WebApr 9, 2024 · Cytokinetics Trading Up 0.7 %. Cytokinetics stock opened at $36.42 on Friday. The business’s 50 day simple moving average is $39.79 and its 200 day simple moving average is $42.22.
WebMar 6, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.
WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The institutional investor owned 961 shares of the biopharmaceutical … foam piece for headset microphoneWebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … foam picture frame kitsWebDec 20, 2024 · The CSPAs provide for the sale and issuance to the RTW Investors of 511,182 shares of Cytokinetics common stock of (the "Shares") with an aggregate purchase price of $20.0 million at a price per share of $39.125. The closing will occur on December 20, 2024. foam piece for the scarlett studioWebMar 4, 2024 · The most optimistic Cytokinetics analyst has a price target of US$75.00 per share, while the most pessimistic values it at US$46.00. Analysts definitely have varying views on the business, but... foam picture frame craft kitsWebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... greenwood indiana flower shopsWebCytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 36.42 +0.26 (+0.72%) At close: 04:00PM EDT. 35.69 -0.73 ( … foam picture frames 4x6WebApr 6, 2024 · CYTK Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cytokinetics Inc. Cytokinetics, Inc. is a biopharmaceutical company, which is … Ligand Pharmaceuticals stock price target raised to $155 from $135 at Benchmark … ACOR Complete Acorda Therapeutics Inc. stock news by MarketWatch. View real … Cytokinetics Inc. analyst estimates, including CYTK earnings per share … Cytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK … Cytokinetics Inc. advanced stock charts by MarketWatch. View CYTK historial stock … greenwood indiana funeral home obituaries